So says a new review in the journal Science, which declares that the club drug is vastly more effective than the serotonin-boosting antidepressants typically prescribed for mood disorders. Via TIME Healthland:
It didn’t seem likely that a drug could repair brain cells within hours, but new research explored suggests just that. Ketamine rapidly spurs the growth of new synapses, the connections between brain cells, and is associated with “reversal of the atrophy caused by chronic stress,” the authors write.
Unfortunately, the hallucinogenic effects of ketamine mean that it can’t be used in the same way typical antidepressants are, and fears about its potential for misuse also hamper its development. Researchers are frantically trying to develop compounds that have the same effects as ketamine without producing a “high.”
In the meanwhile, however, ketamine is already FDA approved […] But clinical use of the drug in the community remains rare. Fears about abuse continue to run high, though ketamine has never caught on as a major street drug. If the Science paper’s authors are right that ketamine’s effect on depression is a key advance — and if the drug really holds similar promise for bipolar disorder — patients might want to consider pushing for greater access. Ketamine is off patent, so no drug maker is likely to do so.